Introduction Medullary thyroid carcinoma (MTC) is a neuroendocrine thyroid carcinoma with
parafollicular C cell differentiation. It can occur in either sporadic or hereditary form. Surgery …

We conducted this study to evaluate the demography, clinical presentation, management
and outcomes of medullary thyroid carcinoma (MTC) from the Indian context. This was a …

Medullary thyroid carcinoma (MTC) is an uncommon malignancy of neuroendocrine origin
derived from the parafollicular C cells. Although infrequent, the interest in this cancer …

Objective Medullary thyroid carcinoma (MTC) has varying clinical course. We assessed
trends in MTC presentation during the last 34 years. Design Retrospective study. Methods …

Purpose: Medullary thyroid carcinoma (MTC) is a rare neuroendocrine malignancy with
relatively early lymphatic metastatic spread. The clinical features of MTC remain …

Aims: An audit was conducted to evaluate the demography, clinical presentation,
management, and outcome of MTC in a tertiary care center in South India. Settings and …

Background Medullary thyroid carcinoma (MTC) is a rare C cells‐derived tumor, with a
hardly predictable long‐term prognosis. This study was aimed to evaluate the predictive …

Objective This review outlines advances in the diagnosis, genetic testing, and progress in
medullary thyroid cancer (MTC) treatment in light of the most recent evidence. Methods …

Background Medullary thyroid carcinoma (MTC) is a rare development of thyroid cancer with
a no negligible mortality rate. Our aim was to determine factors that predict outcome in …

Introduction Medullary thyroid carcinoma (MTC) originates from the thyroid parafollicular
cells and accounts for 3% to 10% of all thyroid malignancies. Approximately 84% of cases …